INT11919
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
In addition to positive carcinoembryonic antigen and cytokeratin, the argyrophilic cancer cells were immunoreactive for neuron-specific enolase, chromogranin A, serotonin, neuropeptide Y, glicentin, somatostatin, neurotensin and calcitonin. | |||||||||||||||
| |||||||||||||||
|
The argyrophilic tumor cells with occasional mitoses and focal venous involvement predominantly showed immunoreactivity of cytokeratin, neuron-specific enolase, cystatin C, chromogranin A, calcitonin and neuropeptide Y (NPY). | |||||||||||||||
| |||||||||||||||
|
Immunohistochemistry revealed strong positivity for cytokeratin 20 (Figure 4c) and neurofilament (not shown) in the characteristic dot-like pattern and a weak expression of chromogranin A (Figure 4d). | |||||||||||||||
| |||||||||||||||
|
We note that except for low values of k1 and b, P5 performance is relatively insensitive to parameter settings (more on this below). | |||||||||||||||
| |||||||||||||||
|
The association of intermediate filaments with desmosomal junctions in meningiomas, arachnoid membrane, and arachnoid granulations was first reported by Kartenbeck et al. and Schwecheimer et al. [10,14], who demonstrated that desmosomal plaques anchored vimentin filaments, while cytokeratin immunoreactivity within these tissues was not found. | |||||||||||||||
| |||||||||||||||
|
Immunohistochemistry showed that the neoplastic cells were positive for smooth muscle actin and for h-caldesmon and negative for CD34, calponin, FVIII-associated antigen, S100, EMA and cytokeratin AE1 AE3. | |||||||||||||||
| |||||||||||||||
|
The presence of L3287del mutation in five affected members (II-1, II-2, III-2, III-4, and III-6) but its absence in eight unaffected members of PK002 family were demonstrated (Figure 5D).
| |||||||||||||||
| |||||||||||||||
|
Obvious mobility shifts in the MRF-SSCP analysis were observed in SI-7 PCR product from PKD1 cDNA of an affected member (II-1) of this family when compared with the normal counterparts (Figure 5A). | |||||||||||||||
| |||||||||||||||
|
Mutation segregation analysis by Eco0109 I digestion of amplified genomic DNA samples in the family PK039 showed that three affected members (I-1, I-2, and II-1) carried the mutation while a non-affected person (II-2) did not (Figure 4C). | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.